Shifting to Biomarkers, Proteome Systems Changes Name to Tyrian Diagnostics | GenomeWeb
NEW YORK (GenomeWeb News) – Proteome Systems’ shareholders have agreed to change the name of the company to Tyrian Diagnostics in order to reflect its shift toward a biomarker-based diagnostics business, the company said today.
 
Tyrian Diagnostics said the renaming completes the moves the company has been making to focus on biomarkers.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.